1.5M
Downloads
1182
Episodes
Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com
Episodes

11 hours ago
11 hours ago
53 min
Drs. Jack Cush & Arthur Kavanaugh, two of rheumatology’s most trusted voices, provide a breakdown of the latest breakthroughs and hottest topics in rheumatology from the ACR 2026 meeting in Orlando.
REGISTER TODAY: RheumNow.Live 2027 | January 29 - January 31, 2027
2 days ago
2 days ago
6 min
Dr. Cush reviews best reasons to go to ACR annually, but also the best way to learn ACR26 content available at RheumNow.com this year.
1. Review the Daily Recaps. Four are available.
2. Catch the Rheumatology Roundup with Dr. Jack Cush and Dr. Artie Kavanaugh
3. Enjoy compilations of topics such as PsA, obesity, ILD, Fibromyalgia, CAR-T beginning next week
4. Read faculty articles and watch faculty videos on a range of topics

3 days ago
3 days ago
31 min
Disease Activity in RA-ILD Worse Survival, Unclear Lung Progression
New Rheumatic Disease after CAR-T
UPSTAND study widespread pain responding to JAK inhibition
Three Factors Shape Vaccine Response in Immune-Mediated Inflammatory Disease
Biologics after Cancer Is it Safe
The InVivo Wave Hype or Hope
Biologics vs JAKi MACE and VTE Risk in PsA

4 days ago
4 days ago
44 min
Join RheumNow for a live recap of Day 4 of ACR Convergence 2026. Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice. Faculty: Dr. Jiha Lee Dr. Licia Mota Dr. Mini Dey Dr. Richard Conway Moderator: Dr. David Liew

4 days ago
4 days ago
34 min
Belimumab and Rituximab for SLE A Successful Trial
CAR-T in Rheumatoid Arthritis will it stay
Head to Head JAK vs JAK in RA
JAK1 TYK2i beats Tofacitinib in Active RA
JAKi Cardiovascular Safety in Younger Adults
Low PREVENT Score, Real Risk Coronary Calcium and Heart Failure in Lupus
New Therapy for Fibromyalgia
One dose for every body Rethinking drug exposure
Tirzepitide Add on or start together in PsA
Treating joints and weight together TOGETHER PSA
Two targets or one CAR-T in Lupus Nephritis
Interstitial Pneumonia with Autoimmune Features (IPAF)

5 days ago
5 days ago
41 min
Can a smartphone identify inflammatory arthritis
Can Gut Candida Trigger Rheumatoid Arthritis Maybe
CAR T Without Lymphodepletion
First theranostic approach to treat difficult-to-treat RA
Lifestyle Interventions and Biological Effects in RA
New Rheumatic Disease after CAR-T
Pain in axSpA may Reflect More than Inflammation
Preliminary PK, PD, Clinical and Safety Data of NK019 in Myositis
Real World of SARD ILD
Use of JAK Inhibitors in Rheumatoid Arthritis-Interstitial Lung Disease
VALORous Efforts in Dermatomyositis Interstitial Lung Disease
Who Manages Fibromyalgia

5 days ago
5 days ago
37 min
Proteinuria Another one bites the dust in lupus nephritis
Silent Drifts Non adherence and inflammation in SLE
The Lupus Outcomes Gap
Myositis Hurts
Nociplastic Pain in axSpA
GLP-1 A game changer for lung health
Incidence of Obesity Overweight in PsA Four in Five
Retatrutide for knee osteoarthritis and obesity
Tirzepitide Add on or start together in PsA
BE BOLD Bimekizumab beats Risankizumab in PsA

5 days ago
5 days ago
48 min
Join RheumNow for a live recap of Day 3 of ACR Convergence 2026.
Our expert faculty will highlight key abstracts, emerging research, and clinical insights from the day’s sessions, offering perspective on what these findings may mean for rheumatology practice.
Panelist:
Dr. Bella Mehta
Dr. Brian Jaros
Dr. Henrique Dalomin
Dr. Sheila Reyes
Moderator: Dr. David Liew

5 days ago
5 days ago
25 min
SGLT2 Inhibitors in Lupus Nephritis
Not Seronegative Rheumatoid Arthritis-Interstitial Lung Disease
Anti-CCP Antibody Testing on the Spot
Lessons learned from ReBioLup data in Lupus Nephritis

5 days ago
5 days ago
31 min
RA-ILD and Lung Cancer
Good News and Bad News for CCP+ at Risk for RA
Sex Differences in Psoriatic Arthritis
Drugs in Lupus Nephritis Save Kidney Function, Increase Survival
What Happens to Muscle Mass and Muscle Strength in RA
GLP-1 Agonists in Psoriatic Arthritis
Infliximab Biosimilar Switching
